RxDoctor Payments Data

Evan Allen, MD

Family Medicine · Henderson, NVNPI 1710980743

Payments from drug & device makers

$947in general payments, 2019–2025

Across 53 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$104
  • NEW World Medical,inc.$100
  • Abbott$98
  • Pfizer$94
  • Johnson & Johnson$82
  • AstraZeneca$68
  • plus $400 from 13 others

What the payments were for

  • Food & beverage$947100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$947 in reported general payments places this provider in the 65th percentile of 902 family medicine providers in Nevada.

See all family medicine providers in Nevada

Medicare billing

Part B allowed, 2024
$43,865
Medicare patients
214
Services billed
410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide53$77,840
MounjaroTirzepatide54$57,517
EliquisApixaban22$36,529
TrulicityDulaglutide30$36,062
FarxigaDapagliflozin Propanediol25$27,196
JardianceEmpagliflozin28$26,181
NexlizetBempedoic Acid/Ezetimibe16$9,427
Ezetimibe196$6,775
Rosuvastatin Calcium150$2,229
Atorvastatin Calcium330$2,166
BreynaBudesonide/Formoterol Fumarate11$2,026
Potassium Citrate ErPotassium Citrate17$1,609
Nebivolol Hcl30$1,417
Levothyroxine Sodium118$1,319
Losartan Potassium141$1,103

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$104$77,84053 claims
PfizerEliquis$94$36,52922 claims
AstraZenecaFarxiga$68$27,19625 claims
Esperion Therapeutics, Inc.Nexlizet$17$9,42716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 902 family medicine providers in Nevada.

Other family medicine in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →